Cancer immunotherapy was once regarded as the key node of cancer treatment; however, due to the existence of immune checkpoints such as PD1, PDL1, and CTLA-4, cancer immunotherapy is limited to a certain extent (152–154). Here, PDCD1 is linked to cancer.